UBS Group AG - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 35 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2016. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$4,000
-75.0%
8,513
+30.6%
0.00%
Q1 2018$16,000
+300.0%
6,516
+297.8%
0.00%
Q4 2017$4,000
-50.0%
1,638
-37.9%
0.00%
Q3 2017$8,000
+60.0%
2,637
+131.1%
0.00%
Q2 2017$5,000
+66.7%
1,141
+45.9%
0.00%
Q1 2017$3,000
-50.0%
782
-73.6%
0.00%
Q4 2016$6,0002,9660.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$777,0000.14%
SEARLE & CO. 17,250$64,0000.04%
Jefferies Group LLC 259,200$959,0000.01%
Renaissance Technologies 740,650$2,740,0000.00%
Virtu KCG Holdings LLC 28,739$106,0000.00%
GROUP ONE TRADING, L.P. 19,945$74,0000.00%
SIMPLEX TRADING, LLC 4,950$18,0000.00%
IFP Advisors, Inc 427$2,0000.00%
Advisor Group, Inc. 177$1,0000.00%
BANK OF AMERICA CORP /DE/ 8,363$31,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders